Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NRF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
OGFR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SCEL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYO1E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUDT16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STOM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC728805 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
ALG5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C22orf15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VEPH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPFIBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NADK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ETV1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STON2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPB41L4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ETV6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on